The research information on using atropine for myopia control is evolving. Previous research indicated 0.01% atropine was best, but newer research says otherwise. In this clinical case, practitioners discuss treatment strategies, which are put in research context with clinical pearls for practice.
A child has an allergic reaction to low dose atropine – or does he? Here practitioners consider the possible causes, with advice for management. We then frame this discussion in view of the evidence-base with take home clinical messages.
Read these three clinical complex atropine cases where general health conditions required careful consideration of atropine prescribing for myopia control.
A two-year-old with high myopia and astigmatism – the discussion included co-management, the best optical correction, and the lifelong management ahead. Read more on managing the myopic toddler.
When fitting orthokeratology for astigmatism, it is important to distinguish between refractive astigmatism and corneal toricity. Factors influencing the speed of response are also discussed.
MCS was hesitating fitting OrthoK to a patient who showed inferior corneal steepening. Her main concern was that OrthoK may
HWN presented this case involving a 32-year-old woman whose myopia onset after having her first child and had progressed since.
In a fascinating case, AJ is looking for treatment recommendations for her 7-year-old patient who has very high myopia and
SN shared a clinical case on our Facebook group that involved managing extreme anisometropia. This involved a 9-year-old anisometropic amblyope
PC posed a question regarding the acceptable amount of over-correction to incorporate in an OrthoK prescription to allow for good
